{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer potential", "betulonic acid", "breast cancer", "melanoma"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38674101", "DateCompleted": {"Year": "2024", "Month": "04", "Day": "27"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["4517", "10.3390/ijms25084517"], "ArticleDate": [{"Year": "2024", "Month": "04", "Day": "20"}], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "25", "Issue": "8", "PubDate": {"Year": "2024", "Month": "Apr", "Day": "20"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Synthesis, Pharmacokinetic Profile, Anticancer Activity and Toxicity of the New Amides of Betulonic Acid-In Silico and In Vitro Study.", "Abstract": {"AbstractText": ["Betulonic acid (B(O)A) is a pentacyclic lupane-type triterpenoid that widely exists in plants. There are scientific reports indicating anticancer activity of B(O)A, as well as the amides and esters of this triterpenoid. In the first step of the study, the synthesis of novel amide derivatives of B(O)A containing an acetylenic moiety was developed. Subsequently, the medium-soluble compounds (EB171 and EB173) and the parent compound, i.e., B(O)A, were investigated for potential cytotoxic activity against breast cancer (MCF-7 and MDA-MB-231) and melanoma (C32, COLO 829 and A375) cell lines, as well as normal human fibroblasts. Screening analysis using the WST-1 test was applied. Moreover, the lipophilicity and ADME parameters of the obtained derivatives were determined using experimental and in silico methods. The toxicity assay using zebrafish embryos and larvae was also performed. The study showed that the compound EB171 exhibited a significant cytotoxic effect on cancer cell lines: MCF-7, A-375 and COLO 829, while it did not affect the survival of normal cells. Moreover, studies on embryos and larvae showed no toxicity of EB171 in an animal model. Compared to EB171, the compound EB173 had a weaker effect on all tested cancer cell lines and produced less desirable effects against normal cells. The results of the WST-1 assay obtained for B(O)A revealed its strong cytotoxic activity on the examined cancer cell lines, but also on normal cells. In conclusion, this article describes new derivatives of betulonic acid-from synthesis to biological properties. The results allowed to indicate a promising direction for the functionalization of B(O)A to obtain derivatives with selective anticancer activity and low toxicity."]}, "AuthorList": [{"Identifier": ["0000-0001-5592-4161"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiello\u0144ska, 41-200 Sosnowiec, Poland."}], "LastName": "B\u0119benek", "ForeName": "Ewa", "Initials": "E"}, {"Identifier": ["0000-0001-7892-0462"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiello\u0144ska, 41-200 Sosnowiec, Poland."}], "LastName": "Rzepka", "ForeName": "Zuzanna", "Initials": "Z"}, {"Identifier": ["0000-0002-3985-4244"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland."}, {"Identifier": [], "Affiliation": "Department of Clinical Pharmacy, Medical University of Bialystok, Mickiewicza 2c, 15-222 Bialystok, Poland."}], "LastName": "Hermanowicz", "ForeName": "Justyna Magdalena", "Initials": "JM"}, {"Identifier": ["0000-0001-9038-3444"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Organic Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiello\u0144ska, 41-200 Sosnowiec, Poland."}], "LastName": "Chrobak", "ForeName": "Elwira", "Initials": "E"}, {"Identifier": ["0000-0003-4475-873X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, Medical University of Bialystok, Kilinskiego 1, 15-089 Bialystok, Poland."}], "LastName": "Sura\u017cy\u0144ski", "ForeName": "Arkadiusz", "Initials": "A"}, {"Identifier": ["0000-0003-2247-3004"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiello\u0144ska, 41-200 Sosnowiec, Poland."}], "LastName": "Beberok", "ForeName": "Artur", "Initials": "A"}, {"Identifier": ["0000-0002-6918-3330"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 4 Jagiello\u0144ska, 41-200 Sosnowiec, Poland."}], "LastName": "Wrze\u015bniok", "ForeName": "Dorota", "Initials": "D"}], "GrantList": [{"GrantID": "BNW-1-012/K/3/F; BNW-2-010/K/3/F.", "Agency": "Medical Univeristy of Silesia in Katowice", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "betulonic acid"}, {"RegistryNumber": "0", "NameOfSubstance": "Amides"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "6SMK8R7TGJ", "NameOfSubstance": "Oleanolic Acid"}, {"RegistryNumber": "4G6A18707N", "NameOfSubstance": "Betulinic Acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Amides"}, {"QualifierName": ["pharmacology", "chemistry", "chemical synthesis", "pharmacokinetics"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Zebrafish"}, {"QualifierName": ["analogs & derivatives", "pharmacology", "chemistry", "chemical synthesis", "pharmacokinetics"], "DescriptorName": "Oleanolic Acid"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Computer Simulation"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Betulinic Acid"}], "CoiStatement": "The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Soerjomataram I., Bray F. Planning for tomorrow: Global cancer incidence and the role of prevention 2020\u20132070. Nat. Rev. Clin. Oncol. 2021;18:663\u2013672. doi: 10.1038/s41571-021-00514-z.", "ArticleIdList": ["10.1038/s41571-021-00514-z", "34079102"]}, {"Citation": "Leong K.H., Mahdzir M.A., Din M.F.M., Awang K., Tanaka Y., Kulkeaw K., Ishitani T., Sugiyama D. Induction of intrinsic apoptosis in leukaemia stem cells and in vivo zebrafish model by betulonic acid isolated from Walsura pinnata Hassk (Meliaceae) Phytomedicine. 2017;26:11\u201321. doi: 10.1016/j.phymed.2016.12.018.", "ArticleIdList": ["10.1016/j.phymed.2016.12.018", "28257660"]}, {"Citation": "Yang S., Zhao Q., Xiang H., Liu M., Zhang Q., Xue W., Song B., Yang S. Antiproliferative activity and apoptosis-inducing mechanism of constituents from Toona sinensi on human cancer cells. Cancer Cell Int. 2013;13:12. doi: 10.1186/1475-2867-13-12.", "ArticleIdList": ["10.1186/1475-2867-13-12", "PMC3620677", "23394678"]}, {"Citation": "Song L., Zhang L., Xu L., Ma Y., Lian W., Liu Y., Wang Y. Optimized extraction of total triterpenoids from Jujube (Ziziphus jujuba Mill.) and comprehensive analysis of triterpenic acids in different cultivars. Plants. 2020;9:412. doi: 10.3390/plants9040412.", "ArticleIdList": ["10.3390/plants9040412", "PMC7238538", "32230740"]}, {"Citation": "Li G.L., You J.M., Song C.H., Xia L., Zheng J., Suo Y.R. Development of a new HPLC method with precolumn fluorescent derivatization for rapid, selective and sensitive detection of triterpenic acids in fruits. J. Agric. Food Chem. 2011;59:2972\u20132979. doi: 10.1021/jf104224t.", "ArticleIdList": ["10.1021/jf104224t", "21388126"]}, {"Citation": "Mal\u00edk M., Velechovsk\u00fd J., Tlusto\u0161 P. Natural pentacyclic triterpenoid acids potentially useful as biocompatible nanocarriers. Fitoterapia. 2021;151:104845. doi: 10.1016/j.fitote.2021.104845.", "ArticleIdList": ["10.1016/j.fitote.2021.104845", "33684460"]}, {"Citation": "Juang F.C., Chen Y.F., Lin F.M., Huang K.F. Constituents from the leaves of Lantana camara (IV) J. Chin. Med. 2005;16:149\u2013155."}, {"Citation": "Popov S.A., Kozlova L.P., Kornaukhova L.M., Shpatov A.V. Simple and efficient process for large scale preparation of betulonic acid from birch bark extracts. Ind. Crops Prod. 2016;92:197\u2013200. doi: 10.1016/j.indcrop.2016.07.026.", "ArticleIdList": ["10.1016/j.indcrop.2016.07.026"]}, {"Citation": "Ryu S.Y., Choi S.U., Lee S.H., Lee C.O., No Z., Ahn J.W. Antitumor triterpenes from medicinal plants. Arch. Pharm. Res. 1994;17:375\u2013377. doi: 10.1007/BF02974180.", "ArticleIdList": ["10.1007/BF02974180"]}, {"Citation": "Shintyapina A.B., Shults E.E., Petrenko N.I., Uzenkova N.V., Tolstikov G.A., Pronkina N.V., Kozhevnikov V.S., Pokrovskya A.G. Effect of nitrogen-containing derivatives of the plant triterpenes betulin and glycyrrhetic acid on the growth of MT-4, MOLT-4, CEM, and Hep G2 tumor cells. Russ. J. Bioorg. Chem. 2007;33:579\u2013583. doi: 10.1134/S1068162007060076.", "ArticleIdList": ["10.1134/S1068162007060076", "18173125"]}, {"Citation": "Shu Y., Li F., Han Y., Wang P., Gao F., Yan M., Liang M., Ma Q., Zhang Y., Ding X., et al. Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents. Front. Chem. 2022;10:969770. doi: 10.3389/fchem.2022.969770.", "ArticleIdList": ["10.3389/fchem.2022.969770", "PMC9486541", "36147251"]}, {"Citation": "Yang S.J., Liu M.C., Zhao Q., Hu D.Y., Xue W., Yang S. Synthesis and biological evaluation of betulonic acid derivatives as antitumor agents. Eur. J. Med. Chem. 2015;96:58\u201365. doi: 10.1016/j.ejmech.2015.04.006.", "ArticleIdList": ["10.1016/j.ejmech.2015.04.006", "25874331"]}, {"Citation": "Baltina L.A., Flekhter O.B., Nigmatullina L.R., Boreko E.I., Pavlova N.I., Nikolaeva S.N., Savinova O.V., Tolstikova G.A. Lupane triterpenes and derivatives with antiviral activity. Bioorg. Med. Chem. Lett. 2003;13:3549\u20133552. doi: 10.1016/S0960-894X(03)00714-5.", "ArticleIdList": ["10.1016/S0960-894X(03)00714-5", "14505668"]}, {"Citation": "Cheresiz S.V., Kononona A.A., Skarnovich M., Volkova A.N., Poletaeva Yu A., Emaminia F., Pyankov O.V., Schultz E.E., Pokrovsky A.G. An amide derivative of betulonic acid as a new inhibitor of Sars-CoV-2 spike protein-mediated cell entry and Sars-CoV-2 infection. Insights Chem. Biochem. 2022;2:ICBC. MS.ID.000535"}, {"Citation": "Khlebnicova T.S., Piven Y.A., Baranovsky A.V., Lakhvich F.A., Sorokina I.V., Tolstikova T.G. Fluorine-containing lupane triterpenoid acid derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory agents. Steroids. 2019;147:62\u201369. doi: 10.1016/j.steroids.2018.10.001.", "ArticleIdList": ["10.1016/j.steroids.2018.10.001", "30296549"]}, {"Citation": "Chue K.T., Chang M.S., Ten L.N. Synthesis and antibacterial activity of betulonic acid amides with piperazine derivatives. Chem. Nat. Compd. 2011;47:759\u2013763. doi: 10.1007/s10600-011-0051-x.", "ArticleIdList": ["10.1007/s10600-011-0051-x"]}, {"Citation": "Tsepaeva O.V., Nemtarev A.V., Salikhova T.I., Abdullin T.I., Grigor Eva L.R., Khozyainova S.A., Mironov V.F. Synthesis, anticancer, and antibacterial activity of betulinic and betulonic acid C-28-triphenylphosphonium conjugates with variable alkyl linker length. Anticancer Agents Med. Chem. 2020;20:286\u2013300. doi: 10.2174/1871520619666191014153554.", "ArticleIdList": ["10.2174/1871520619666191014153554", "31660842"]}, {"Citation": "Rzepka Z., B\u0119benek E., Chrobak E., Wrze\u015bniok D. Synthesis and anticancer activity of indole-functionalized derivatives of betulin. Pharmaceutics. 2022;14:2372. doi: 10.3390/pharmaceutics14112372.", "ArticleIdList": ["10.3390/pharmaceutics14112372", "PMC9694481", "36365190"]}, {"Citation": "B\u0119benek E., Chrobak E., Rzepka Z., Wrze\u015bniok D. New betulin derivatives with nitrogen heterocyclic moiety-synthesis and anticancer activity in vitro. Biomolecules. 2022;12:1540. doi: 10.3390/biom12101540.", "ArticleIdList": ["10.3390/biom12101540", "PMC9599051", "36291749"]}, {"Citation": "Demets O.V., Takibayeva A.T., Kassenov R.Z., Aliyeva M.R. Methods of betulin extraction from birch bark. Molecules. 2022;27:3621. doi: 10.3390/molecules27113621.", "ArticleIdList": ["10.3390/molecules27113621", "PMC9181928", "35684557"]}, {"Citation": "Kim D.S.H.L., Chen Z.D., Nguyen V.T., Pezzuto J.M., Qui S.X., Lu Z.Z. A concise semi-synthetic approach to betulinic acid from betulin. Synth. Commun. 1997;27:1607\u20131612. doi: 10.1080/00397919708006099.", "ArticleIdList": ["10.1080/00397919708006099"]}, {"Citation": "Choi S.Z., Yang M.C., Choi S.U., Lee K.R. Cytotoxic terpenes and lignans from the roots of Ainsliaea acerifolia. Arch. Pharm. Res. 2006;29:203\u2013208. doi: 10.1007/BF02969394.", "ArticleIdList": ["10.1007/BF02969394", "16596992"]}, {"Citation": "Guan L., Yang H., Cai Y., Sun L., Di P., Li W., Liu G., Tang Y. ADMET-score\u2014A comprehensive scoring function for evaluation of chemical drug-likeness. Med. Chem. Commun. 2019;10:148\u2013157. doi: 10.1039/C8MD00472B.", "ArticleIdList": ["10.1039/C8MD00472B", "PMC6350845", "30774861"]}, {"Citation": "Miller R.R., Madeira M., Wood H.B., Geissler W.M., Raab C.E., Martin I.J. Integrating the impact of lipophilicity on potency and pharmacokinetic parameters enables the use of diverse chemical space during small molecule drug optimization. J. Med. Chem. 2020;63:12156\u201312170. doi: 10.1021/acs.jmedchem.9b01813.", "ArticleIdList": ["10.1021/acs.jmedchem.9b01813", "32633947"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 1997;23:3\u201325. doi: 10.1016/S0169-409X(96)00423-1.", "ArticleIdList": ["10.1016/S0169-409X(96)00423-1", "11259830"]}, {"Citation": "Ghose A.K., Viswanadhan V.N., Wendoloski J.J. A knowledge-based approach to the design of combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1999;1:55\u201368. doi: 10.1021/cc9800071.", "ArticleIdList": ["10.1021/cc9800071", "10746014"]}, {"Citation": "Veber D.F., Johnson S.R., Cheng H.Y., Smith B.R., Ward K.W., Kopple K.D. Molecular properties affecting the oral bioavailability of drug candidates. J. Med. Chem. 2002;45:2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "Alves V.M., Muratov E., Fourches D., Strickland J., Kleinstreuer N., Andrade C.H., Tropsha A. Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization. Toxicol. Appl. Pharmacol. 2015;284:273\u2013280. doi: 10.1016/j.taap.2014.12.013.", "ArticleIdList": ["10.1016/j.taap.2014.12.013", "PMC4408226", "25560673"]}, {"Citation": "Pires D.E.V., Blundell T.L., Ascher D.B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 2015;58:4066\u20134072. doi: 10.1021/acs.jmedchem.5b00104.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00104", "PMC4434528", "25860834"]}, {"Citation": "Vilar S., Chakrabarti M., Costanzi S. Prediction of passive blood-brain partitioning: Straightforward and effective classification models based on in silico derived physicochemical descriptors. J. Mol. Graph. Model. 2010;28:899\u2013903. doi: 10.1016/j.jmgm.2010.03.010.", "ArticleIdList": ["10.1016/j.jmgm.2010.03.010", "PMC2873098", "20427217"]}, {"Citation": "Kadry H., Noorani B., Cucullo L. A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity. Fluids Barriers CNS. 2020;17:69. doi: 10.1186/s12987-020-00230-3.", "ArticleIdList": ["10.1186/s12987-020-00230-3", "PMC7672931", "33208141"]}, {"Citation": "Sarkar P., Alheety M.A., Srivastava V. Molecular docking and ADMET study of spice-derived potential phytochemicals against human DNA topoisomerase III alpha. Macromol. Symp. 2023;407:2200108. doi: 10.1002/masy.202200108.", "ArticleIdList": ["10.1002/masy.202200108"]}, {"Citation": "Vlad I.M., Nuta D.C., Chirita C., Caproiu M.T., Draghici C., Dumitrascu F., Bleotu C., Avram S., Udrea A.M., Missir A.V., et al. In silico and in vitro experimental studies of new dibenz[b,e]oxepin-11(6H)one O-(arylcarbamoyl)-oximes designed as potential antimicrobial agents. Molecules. 2020;25:321. doi: 10.3390/molecules25020321.", "ArticleIdList": ["10.3390/molecules25020321", "PMC7024208", "31941125"]}, {"Citation": "Westerfield M. The Zebrafish Book. A Guide for the Laboratory Use of Zebrafish (Danio rerio) 4th ed. University of Oregon Press; Eugene, OR, USA: 2000. pp. 154\u2013196."}, {"Citation": "Str\u00e4hle U., Scholz S., Geisler R., Greiner P., Hollert H., Rastegar S., Schumacher A., Selderslaghs I., Weiss C., Witters H., et al. Zebrafish embryos as an alternative to animal experiments\u2014A commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol. 2012;33:128\u2013132. doi: 10.1016/j.reprotox.2011.06.121.", "ArticleIdList": ["10.1016/j.reprotox.2011.06.121", "21726626"]}, {"Citation": "Busquet F., Strecker R., Rawlings J.M., Belanger S.E., Braunbeck T., Carr G.J., Cenijn P., Fochtman P., Gourmelon A., H\u00fcbler N., et al. OECD validation study to assess intra- and inter-laboratory reproducibility of the zebrafish embryo toxicity test for acute aquatic toxicity testing. Regul. Toxicol. Pharmacol. 2014;69:496\u2013511. doi: 10.1016/j.yrtph.2014.05.018.", "ArticleIdList": ["10.1016/j.yrtph.2014.05.018", "24874798"]}, {"Citation": "Kadela-Tomanek M., Jastrz\u0119bska M., Marciniec K., Chrobak E., B\u0119benek E., Boryczka S. Lipophilicity, pharmacokinetic properties, and molecular docking study on SARS-CoV-2 target for betulin triazole derivatives with attached 1,4-quinone. Pharmaceutics. 2021;13:781. doi: 10.3390/pharmaceutics13060781.", "ArticleIdList": ["10.3390/pharmaceutics13060781", "PMC8224687", "34071116"]}]}], "History": [{"Year": "2024", "Month": "2", "Day": "29"}, {"Year": "2024", "Month": "4", "Day": "17"}, {"Year": "2024", "Month": "4", "Day": "18"}, {"Year": "2024", "Month": "4", "Day": "27", "Hour": "9", "Minute": "54"}, {"Year": "2024", "Month": "4", "Day": "27", "Hour": "9", "Minute": "53"}, {"Year": "2024", "Month": "4", "Day": "27", "Hour": "1", "Minute": "15"}, {"Year": "2024", "Month": "4", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["38674101", "PMC11050400", "10.3390/ijms25084517", "ijms25084517"]}}]}